Loading Events
This event has passed.

Pharmaceutical Science in a Changing World

Reflecting the needs for sustainability and diversity in addressing the health of globally connected populations

Register For This Event


Please view the conference at a glance programme

PharmSci 2019 at a glance

Please view the latest programme for PharmSci, which will be updated as speakers announced

PharmaSci 2019 Programme

We are pleased to announce this year’s science chair is Professor Cameron Alexander

Cameron is Professor of Polymer Therapeutics, a Royal Society Wolfson Research Merit Fellow, an EPSRC Impact Fellow, and Head of the Division of Molecular Therapeutics and Formulation at the School of Pharmacy, University of Nottingham, UK.

He received degrees (BSc and PhD) in Chemistry from the University of Durham, UK and carried out post-doctoral research at the Melville Laboratory for Polymer Synthesis, University of Cambridge. He is a Fellow of the Royal Society of Chemistry and the Higher Education Academy, Chair of the Royal Society of Chemistry Macro Group UK, Chair of the EPSRC Strategic Advisory Team for Physical Sciences and a recent (2009-2014) EPSRC Leadership Fellow. Prof Alexander has published ~ 200 refereed articles in areas ranging from drug delivery and regenerative medicine to synthetic biology, receiving nearly 9000 citations to date. From 2006-2016, Cameron led the EPSRC Centre for Doctoral Training in Advanced Therapeutics and Nanomedicines at Nottingham and University College London with leading pharmaceutical industry partners. He received the Royal Society of Chemistry Macro Group Medal 2014 for contributions to polymer science.
He has been fortunate to work with scientists from more than 20 countries in his research group and is proud to serve the Academy of Pharmaceutical Sciences in the UKPharmSci conference

Contact details: School of Pharmacy, University of Nottingham Boots Science Building, University of Nottingham, Nottingham NG7 2RD UK.
Tel: +44 (0) 115 846 7678; Fax +44 (0)115 951 5102; Cameron.alexander@nottingham.ac.uk


Dr Bruce Alexander, Principal Lecturer in Physical Chemistry, University of Greenwich

Professor Gavin Andrews-Queens University of Belfast.

Dr Suky Bhamra, University of Birmingham.

Jo Craig, SVP CMC, NeRRe & KaNDy Therapeutics.

Dr Michael Devlin, researcher, University of Strathclyde

Juan Domínguez Robles, School of Pharmacy, Queen’s University Belfast.

Professor Dennis Douroumis, University of Greenwich

Taherali Farhan, UCL School of Pharmacy

Sarah Goulding, Innovate UK Knowledge transfer Network (KTN)

Professor Michael Heinrich, UCL School of Pharmacy

Dr Andreea Iftimia-Manders- Enabling Programmes,UK Research and Innovation

Proffessor Trevor M Jones CBE FMedSci

Majella Lane, Senior Lecturer Pharmaceutics, University College London

Laura Mason, Upperton Pharma Solutions (UKICRS Treasurer)

Mark McAllister-Chair of APS,Pfizer

Professor Helen Osborn, Professor of Biomedicinal Chemistry, University of Reading

Dr Sheng Qi, University of East Anglia.

Dr Allan Jordan, Director of Oncology Drug Discovery, Sygnature Discovery.

Professor Andrew Lewis, VP R&D, Biocompatibles UK Ltd

Dr Maria Marlow, University of Nottingham

Dr Zahra Rattray, Chancellor’s Fellow and Lecturer, Strathclyde Institute of Pharmacy and Biomedical Sciences

Dr Matt Reason, Materials Technical Lead, GSK

Dr Steven Ross, University of Greenwich.

David Scurr, University of Nottingham

Professor Martin Snowden, Pro Vice Chancellor, University of Greenwich

Dr Silvia Sonzini, Senior Scientist, AstraZeneca

David Streather, Astra Zeneca

Professor Laura Waters, University of Huddersfield


Heba Abdelwahab, PhD Student, School of Pharmacy, Queen’s university Belfast.

Prof Abdul Basit-UCL, School of Pharmacy.

Dr Thais Abelha, Research Fellow, University of Nottingham

Dr Bruce Alexander, Principal Lecturer in Physical Chemistry, University of Greenwich

Dr Joshua Boateng, University of Greenwich at Medway

Dr Cynthia Bosquillon, University of Nottingham

Dr Asma Buanz,UCL School of Pharmacy

Dr Fungayi Chidothe MD, Head of Strategy and Planning, Cell and Gene Therapy Catapult

Neil Dawson, Pfizer

Michael Devlin, PhD researcher, University of Strathclyde

Andi Dian Permana, PhD Student, School of Pharmacy, Queens University Belfast

Juan Domínguez Robles, School of Pharmacy, Queen’s University Belfast

Dr Alexander Edwards, Associate Professor, University of Reading

Professor Dr Thomas Efferth, Editor-in- Chief, Phytomedicine Chair, Department of Pharmaceutical Biology, Institute of Pharmacy and Biochemistry Johannes Gutenberg University

Professor Rachel Elliott, Professor of Health Economics, Deputy Centre Lead, Manchester Centre for Health

Farnaz Esmaeili-GSK

David Evans, Technical Product Manager, Genvolt Ltd

Idowu Eniafe Fadayomi, PhD Student, Keele University

Taherali Farhan, UCL School of Pharmacy

Dr Enrico Ferrari, Senior Lecturer, University of Lincoln

Dr Mark Frigerio, Ph.D Director, Chemistry UK, Abzena

Elliott Higgin, Postgraduate Research Student, King’s College London

Dr Nathalie Lavignac, Lecturer, Medway School of Pharmacy

Professor Andrew Lewis, VP R&D, Biocompatibles UK Ltd

Dr Ashraf Ismail Mcgill, University of Greenwich

Dr Keng Wooi Ng, Lecturer, Newcastle University

Dr Asma Patel, Senior Director Development, Quotient Sciences

Mr Jean Philippe Ganay, Pfizer

Dr Pratik Gurnani, Research Fellow, University of Nottingham

Professor Julie Hawkins, Professor of Plant Systematics and Evolution, School of Biological Sciences, University of Reading

Professor Michael Heinrich, UCL School of Pharmacy

Elliott Higgin, Postgraduate Research Student, King’s College London

David Jones, Pro-Vice-Chancellor for Education and Students at Queen’s University Belfast

Dr Yaroslav Khimyak- University of East Anglia

Dr Kristof Kimpe- Formulate me tinder

Professor Twan Lammers, Head of Department Nanomedicine and Theranostics, RWTH Aachen University

Dr Nathalie Lavignac, Lecturer, Medway School of Pharmacy

Dr Mridul Majumder, BPharm Founder & Director, M2M Pharmaceuticals Ltd

Emma McAlister, Research Fellow, Queen’s University Belfast

Dr Ashraf Ismail Mcgill, University of Greenwich

Az Alddien Natfji, PhD Student, School of Pharmacy, University of Reading

Professor Fergal O’Brien, Professor of Bioengineering and Regenerative Medicine, Royal College of Surgeons in Ireland

Angela Osborne, Managing Director, ATMP Manufacturing Community.

Florence Osuagwu, MPharm Student, Keele University

David Parmley- Centre for Process Innovation.

Asha Kumari Patel, Lecturer in Cell & Gene Therapy, Imperial College London

Yvonne Pendry, University of Greenwich

Jean Philippe Panay-Pfizer

Dr Kendal Pitt-Senior Technical Director, Pharma Supply Chain, GSK

Anne Marie Pordon, Publisher Pharmacology and Pharmaceutical Sciences, Elsevier

Jukka Rantanen, professor of pharmaceutical technology and engineering at the Department of Pharmacy,University of Copenhagen

Professor Clive Roberts, Professor of Pharmaceutical Nanotechnology, Head of School of Pharmacy, University of Nottingham

Dr Simon Roberts, Account Manager (Pharmaceuticals, UK & Ireland), Ashland Specialties UK Ltd

Dr Steven Ross, University of Greenwich

Dr Bruno Sil dos Santos, Lecturer in Pharmaceutical Science and Pharmacology, School of Human Sciences, London Metropolitan University

Dr Hélder A. Santos, Associate Professor, University of Helsinki

Dr Floriane Séquier, Team Leader, Global Product Development, AstraZeneca

Silvia Sonzini, Senior Scientist, AstraZeneca

Professor Robin Shattock- Imperial College London.

Dr Nachal Subramanian, Sales Executive -Benelux

Sarah J Trenfield, UCL School of Pharmacy

Hetvi Triboandas, PhD student, De Montfort University

Dr Maria J. Vicent, PhD, Polymer Therapeutics Lab, Centro de Investigación príncipe Felipe

Dr Zoe Waller, University of East Anglia

Dr Keng Wooi Ng, Lecturer, Newcastle University

Vipul Yadav, Director of Research, Intract Pharma Ltd

Twan Lammers obtained a DSc degree in Radiation Oncology from Heidelberg University in 2008 and a PhD degree in Pharmaceutics from Utrecht University in 2009. In the same year, he started the Nanomedicine and Theranostics group at RWTH Aachen University Clinic. In 2014, he was promoted to full professor of medicine at RWTH Aachen. He has published over 150 research articles and reviews, and has received several scholarships and award. He is associate editor for Europe for the Journal of Controlled Release. His primary research interests include drug targeting to tumors, image-guided drug delivery and tumor-targeted combination therapies.

Nanomedicines are 1-100(0) nm-sized carrier materials designed to improve the biodistribution and the target site accumulation of systemically administered (chemo-) therapeutic drugs. By delivering drug molecules more efficiently to pathological sites, and by preventing them from accumulating in healthy tissues, nanomedicines are able to improve the balance between efficacy and toxicity. Nanomedicines rely on the Enhanced Permeability and Retention (EPR) effect for efficient target site accumulation, which is notoriously known to be highly variable, both in animal models and in patients. To overcome this high heterogeneity in EPR, and to improve the (pre-) clinical performance of cancer nanomedicines, we are working on systems and strategies to modulate and monitor tumor-targeted drug delivery. In the present lecture, several “smart” strategies will be highlighted, including pharmacological and physical modulation of tumor blood vessels and the microenvironment, and theranostic concepts for individualized and improved nanomedicine treatment.

Rachel is Professor of Health Economics in the Manchester Centre for Health Economics, University of Manchester, co-Director of the Manchester Clinical Trials Unit and a UK registered pharmacist. She leads applied health economics research across a range of disease areas and types of healthcare technology, securing high profile grants, to a value of over £24 million. Study designs include patient and practice-level cluster trials, stepped-wedge designs, quasiexperimental methods supported by large database and routine data interrogation, economic modelling and simulation, close working with clinical and patient expert panels. She working with NICE to develop the use of routine data to develop and evaluate digital health technologies (DHTs), and is working with NICE and Innovate UK to support device, DHT and AI-based intervention development and evaluation. She has been member of a NICE technology appraisal committee since 2006.

Download the full PDF programme here


The deadline for abstract submissions has now passed for review for a podium present.

Currently opportunities are available for late abstracts submissions  are invited for consideration for posters only.

Please contact Valerie Bassigny  (Conference management company for PharmSci) at Valerie.Bassigny@profileproductions.co.uk

This is one of the most exciting parts of the conference as it represents the presentation of the very latest pharmaceutical science research.
Abstracts on any aspect of the Pharmaceutical Sciences are welcomed and those with a particular emphasis on the theme of this year’s Conference, “Pharmaceutical Science in a Changing World” are particularly appreciated.

Details of the various subject categories, an abstract template and details of the entry process can be found here

Please ensure abstracts are submitted online and comply with the Abstract Submission Template.

There will be prizes awarded for winning posters on each day of the Conference and authors of abstracts of particular interest will be invited to give podium presentations (10 minutes) which is part of the main sessions within the conference. This is an excellent chance to get your science recognised at the UK’s premier Pharmaceutical Science Conference.

Past Poster Winners.


The APS received an exceptional pool of nominations this year, and are pleased to announce that

Professor Clive Roberts, Professor of Pharmaceutical Nanotechnology, Head of School of Pharmacy, University of Nottingham will deliver the APS plenary lecture this year.
Clive will deliver a lecture on
“The potential of 3D printing in the development and manufacture of medicines and its impact upon Pharmacy”

Clive has built an outstanding research profile that covers the application of novel analytical and formulation strategies to develop new medicines and biomedical devices. In particular, Clive is internationally known for his accomplishments in additive manufacturing (i.e. 3D printing), with the first example worldwide of ink jetting for drug formulations being published in 2011 (Scoutaris et al, J Control Release 156 (2), 179-185). Clive’s group and collaborations in 3D printing have addressed fundamental scientific issues needed to apply this technology for the printing of solid dosage forms. Much of this seminal work is now being funded by the EPSRC, AZ and GSK and the applications of this work are now being exhibited to the wider public (e.g. London Science Museum and Manchester Industrial Science Museum). Clive is also well known as an inspiring and engaging speaker at all levels, from schools visits through to the most prestigious international conferences (APS and CRS)

The APS plenary lecture award is sponsored by AstraZeneca and is awarded to nominated members of APS who have made an outstanding scientific contribution in their work and are ambassadors of international repute.

The title of Abdul’s talk will be: “Lost in Translation”

His research sits at the interface between pharmaceutical science and gastroenterology and is focused on forging links between basic science and clinical outcomes. Abdul’s research spans the personalisation of medicines using 3D printing and is the inventor of a number of advanced drug delivery technologies, many of which have been translated into marketed products. Abdul leads a large and multi-disciplinary research group and has published over 350 papers, book chapters and abstracts, and delivered more than 250 invited research presentations. Abdul is also a serial entrepreneur and has filed multiple patents and founded 3 pharmaceutical companies (Kuecept, Intract Pharma, FabRx). He is the European Editor of the International Journal of Pharmaceutics, and is the recipient of numerous international awards and has been awarded over £20 million in research grants.

“I am delighted to have won the Emerging Scientist Award and will present my work entitled ‘Nano-assassins for pancreatic cancer therapy’ at this years PharmSci conference in University of Greenwich. “

Dr Clare Hoskins completed her PhD in Pharmaceutics at Robert Gordon University in Aberdeen under Dr Woei Ping Cheng and Professor Paul Kong Thoo Lin. In her PhD studies Clare developed novel comb shaped polymers for drug solubilisation. Following her PhD she was appointed as a postdoctoral researcher at the Institute of Medical Science and Technology (IMSaT), University of Dundee under the guidance of Professor Sir Alfred Cuschieri and Dr Lijun Wang specialising in the use of nanoparticles for regenerative medicine. In 2011 Clare was appointed as Lecturer in Pharmaceutics at Keele University with subsequent promotion to Senior Lecturer in 2016. The main focus of her work is in the development of nanoparticle based image guided and stimuli-responsive drug delivery systems. Dr Hoskins has over ten years of experience in nanomedicine development and has published forty peer-reviewed papers including those in top journals including Journal of Controlled Release and Nanoscale. Dr Hoskins has supervised or is supervising 10 PhD students and more than twenty Masters students. Within the research Institute for Science & Technology in Medicine (ISTM) Dr Hoskins leads Keele Nanopharmaceutics, a vibrant research group whose cutting-edge work in nanomedicine is challenging traditional approaches and pushing past current boundaries in cancer diagnosis and treatment. Dr Hoskins has been supported by Wellcome Trust, Newton-Bhabha & British Council, EPSRC, BBSRC, and the Iraqi Ministry of Higher Education and Scientific Research (MOHESR). Dr Hoskins is the Elected Secretary to the Royal Society of Chemistry, Chemical Nanosciences and Nanotechnology Network. She sits on the British Council Grant Review Panel for Newton Grants.

Sponsorship and Exhibiting-take a look at all the opportunities in our brochure

The conference includes a large pharmaceutical sciences exhibition to highlight big pharma companies, small and medium size enterprises (SMEs), contract research organisations (CROs) and technology suppliers.

This will be held in the Queen Mary Undercroft, so exhibitors will be situated where all refreshments are taken, with many opportunities during the conference for delegates to visit your table and discuss your company and services.

Exhibitors Package

This includes

Table top (approx. 1.75m x 0.8m)

One full delegate Conference Pass

Company name and hyperlink on the Exhibition’ page

Cost of package £1000

One additional exhibitor only pass for the full conference can also be purchased for an additional colleague in your company for £250.

Additional Opportunity this year…….

For an additional fee exhibitors can have a 10-minute slot on the first day of the conference to present their company and technology allowing 5 minutes for questions. These are limited slots and will need to be booked. For our loyal supporters who have exhibited before these can be purchased at a 50 % reduction of £250.

If you have any questions, please contact

Valerie Bassigny
Conference Director

Profile Production (Managing Conference for APS)


Tel +44 (0)20 3725 5840

You can present your brand, company and products to our delegates, meet potential clients and new employees face to face. Use the exhibition space to demonstrate your services and products to over 400 potential partners and customers. The PharmSci Conference 2019 gives you the opportunity to connect with pharmaceutical industry, university research groups UK and globally, professionals and influential experts, and also to connect with future employees from the talented research students.

If you have any questions, please contact

Valerie BassignyConference DirectorProfile Production (Managing Conference for APS)


Tel +44 (0)20 3725 5840

Sponsorship Brochure for PharmSci 2019

Social Events-Opportunity to dine in the finest dinning hall in Europe-Painted Hall

This will take place on the first day and gives an ideal opportunity for delegates, speakers, exhibitors to socialise in the setting of the Queen Anne Courtyard. Drinks and food will be served. This is included in the registration cost for the delegate fees on the Wednesday.

Conference Black-Tie Dinner – Thursday 12th September 2019

This will take place in the The Painted Hall which is a striking baroque space designed by Sir Christopher Wren and Nicholas Hawksmoor, and often described as the “finest dining hall in Europe”. It features spectacular wall and ceiling decoration by Sir James Thornhill, who lavished 19 years on this, his masterwork. It has recently been closed for renovation since 2016, so gives the unique opportunity to see the works undertaken.
The black-tie dinner includes the Academy Awards Ceremony where the academy present awards to recognise the contribution of colleagues in the field.
PharmSci 2019 Black Tie Dinner is a prestige event attended by many of the key note speakers, board and advisory board of the Academy.

After dinner speaker will be Prof Ijeoma Uchegbu-UCL, School of Pharmacy.
Book early for a saving on the cost of the ticket.

First 100 delegates £65(ex vat)-saving of  approx 20%
First 20 students £45 (ex vat)-saving of approx 40 %

This is a great networking that we would like to open up to colleagues that can not attend the conference

External APS member external folk- £90 (ex vat)
External folk (not registered at the conference) and partners £100 (ex vat)

Accommodation and Venue

Located in the heart of Greenwich and overlooking the River Thames. Getting There.

The Greenwich Campus is on a World Heritage Site on the banks of the River Thames. The university’s largest campus is centred on three baroque buildings designed by Sir Christopher Wren at the end of the 17th century. The Independent newspaper described it as “more breathtaking than the Versailles of Louis XIV”. Read More.

Greenwich is a popular area in East London and accommodation can be found nearby in numerous hotels.

Delegates are able to book fully inclusive places at the conference, to include accommodation at the Travelodge in Greenwich or rooms within the University of Greenwich.

Travelodge London Greenwich

Double room for single or double occupancy, price doesn’t change.

11/09/2019- Double room £99-111

12/09/2019-Double room-£65-81

University of Greenwich

Single room only-can be booked for 10,11 & 12 September 2019-£50/night

All rooms are ensuite and are set out in a flat formation, each room contains the standard study-bedroom fittings (bed, bedside table, desk, chair, wardrobe, pinboard. Towels and shower gel are provided.

The address of the halls is:
Daniel Defoe Halls, University of Greenwich,10 Lovibond Lane, London SE10 9FY (located near the corner of Waller Way and Greenwich High Road).

Registration fees

Members 1 day (Wed & Social) 2 days (Thus & Fri) 3 days (Wed & Social, Thurs & Fri)
Industry Members £195 £320 £470
Academic Member £141 £236 £350
Student Member £75.50 £123 £180
Industry Non-Member £255 £380 £530
Academic Non-Member £201 £296 £410
Student Non-Member £95.50 £143 £200

The social networking event on Wednesday  11th September is include in the delegate rate for that day.

This will take place on the first day and gives an ideal opportunity for delegates, speakers, exhibitors to socialise in the setting of the Queen Anne Courtyard. Drinks and food will be served.

The Conference Black-Tie Dinner  is on the Thursday 12th September 2019 and will take place in the The Painted Hall. This can be booked separately when you register.

All prices specified in the price list are given exclusive of VAT.

Gold Sponsors

Bronze Sponsors

Black Tie Dinner – Red Carpet Sponsor

Register For This Event